Alpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1235-1243

  Bockman, Charles S ^a   Gonzalez Cabrera, Isabel ^a   Abel, Peter W ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CLONIDINE; GUANABENZ; NITRIC OXIDE; NORADRENALIN; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CARDIOVASCULAR DISEASE; CHOLINERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERIOR MESENTERIC ARTERY; VASODILATATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CYCLIC AMP; ENDOTHELIUM, VASCULAR; FORSKOLIN; KINETICS; MESENTERIC ARTERIES; NITRIC OXIDE; QUINOXALINES; RATS; RECEPTORS, ADRENERGIC, ALPHA-2; SWINE; VASODILATION;

EID: 0030441053     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. ANGUS, J. A., COCKS, T. M. AND SATOH, K.: The α adrenoceptors on endothelial cells. Fed. Proc. 45: 2355-2359, 1986.
2. ARUNLAKSHANA, O. AND SCHILD, H. O.: Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14: 48-58, 1959.
3. BLAXALL, H. S., HASS, N. A. AND BYLUND, D. B.: Expression of alpha-2 adrenergic receptor genes in rat tissues. Receptor 4: 191-199, 1994a.
4. BLAXALL, H. S., HECK, D. A. AND BYLUND, D. B.: Molecular determinants of the alpha-2D adrenergic receptor subtype. Life Sci. 53: PL255-PL259, 1993.
5. BLAXALL, H. S., MURPHY, T. J., BAKER, J. C., RAY, C. AND BYLUND, D. B.: Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. J. Pharmacol. Exp. Ther. 259: 323-329, 1991.
6. BLAXALL, H. S., O'ROURKE, M. F., KOBILKA, B., LOMASNEY, J., IVERSEN, L. J., HECK, D. A. AND BYLUND, D. B.: Species characteristics of alpha-2A/D adrenergic receptors. Can. J. Physiol. Pharmacol. 72: (Suppl. 1), 554., 1994b.
7. BOCKMAN, C. S, JEFFRIES, W. B. AND ABEL, P. W.: Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium. J. Pharmacol. Exp. Ther. 267: 1126-1133, 1993.
8. BOCKMAN, C. S, JEFFRIES, W. B., PETTINGER, W. A. AND ABEL, P. W.: Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension. Hypertension 20: 304-313, 1992.
9. BREDT, D. S., FERRIS, C. D. AND SNYDER, S. H.: Nitric oxide synthase regulatory sites: phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J. Biol. Chem. 267: 10976-10981, 1992.
10. 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol. Pharmacol. 42: 1-5, 1992.
11. BYLUND, D. B., HASS, N. A., CERUTIS, D. R. AND BLAXALL, H. S.: Characterization of alpha-2 adrenergic receptor subtypes. Pharmacol. Commun. 6: 87-90, 1995.
12. BYLUND, D. B. AND RAY-PRENGER, C.: Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype. J. Pharmacol. Exp. Ther. 251: 640-644, 1989.
13. DINERMAN, J. L., LOWENSTEIN, C. J. AND SNYDER, S. H.: Molecular mechanisms of nitric oxide regulation: Potential relevance to cardiovascular disease. Circ. Res. 73: 217-222, 1993.
14. GRAY, D. W. AND MARSHALL, I.: Novel signal transduction pathway mediating endothelium-dependent β-adrenoceptor vasorelaxation in rat thoracic aorta. Br. J. Pharmacol. 107: 684-690, 1992.
15. 2-adrenergic receptor genes. Hypertension 21: 861-865, 1993.
16. 2-adrenergic receptors. Mol. Pharmacol. 40: 407-412, 1991.
17. 2-adrenoceptors. Pharmacol. Commun. 6: 91-97, 1995.
18. KAZANIETZ, M. G. AND ENERO, M. A.: Desensitization of the beta-2 adrenoceptor-mediated vasodilation in rat aorta after prolonged treatment with the beta-2 adrenoceptor agonist clenbuterol. J. Pharmacol. Exp. Ther. 252: 758-763, 1990.
19. KENAKIN, T.: Pharmacologic Analysis of Drug-Receptor Interaction, Raven Press, New York, 1993.
20. 2A-autoreceptors in rabbit atria and kidney. Naunyn-Schmiedeberg Arch. Pharmacol. 352: 31-42, 1995a.
21. 2D-autoreceptors in mouse brain. Naunyn-Schmiedeberg Arch. Pharmacol. 352: 43-48, 1995b.
22. LIMBIRD, L. E.: Receptors linked to inhibition of adenylate cyclase: Additional signaling mechanisms. FASEB J. 2: 2686-2695, 1988.
23. 2-C10 homolog responsible for an interspecies variation in antagonist binding. Mol. Pharmacol. 42: 16-27, 1992.
24. LOMASNEY, J. W., COTECCHIA, S., LEFKOWITZ, R. J. AND CARON, M. G.: Molecular biology of α-adrenergic receptors: implications for receptor classification and for structure-function relationships. Biochim. Biophys. Acta 1095: 127-139, 1991.
25. 2B-adrenoceptor subtypes. Br. J. Pharmacol. 98: 890-897, 1989.
26. 2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur. J. Pharmacol. 118: 123-129, 1985.
27. MONCADA, S., PALMER, R. M. J. AND HIGGS, E. A.: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
28. MURPHY, T. J. AND BYLUND, D. B.: Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line. J. Pharmacol. Exp. Ther. 244: 571- 578, 1988.
29. O'ROURKE, M. F., IVERSEN, L. J., LOMASNEY, J. W. AND BYLUND, D. B.: Species orthologs of the alpha-2A adrenergic receptor: The pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors. J. Pharmacol. Exp. Ther. 271: 735-740, 1994.
30. 2-adrenergic receptor subtype. Proc. Natl. Acad. Sci. U.S.A. 85: 6301-6305, 1988.
31. alpha-2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes. J. Pharmacol. Exp. Ther. 270: 946-957, 1994.
32. 2D-adrenergic receptors in bovine pineal gland. Mol. Pharmacol. 40: 235-241, 1991.
33. 2D-autoreceptors in guinea-pig atria and brain. Naunyn-Schmiedeberg Arch. Pharmacol. 352: 49-57, 1995.
34. 2-adrenoceptors and endothelium-derived relaxing factor. Am. J. Med. 87: (Suppl. 3C), 1S-5S, 1989.
35. 2-C4 adrenergic receptor gene encodes a novel pharmacological subtype. FEBS Lett. 278: 45-50, 1991.
36. WEBB, R. C. AND BOHR, D. F.: Recent advances in the pathogenesis of hypertension: Consideration of structural, functional and metabolic vascular abnormalities resulting in elevated arterial resistance. Am. Heart J. 102: 251-264, 1981.
37. 2B-adrenergic receptor. Mol. Pharmacol. 38: 681-688, 1990.
38. 2B-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 87: 3102-3106, 1990.